Products
MACROPIN
MACROPIN (insulin, human biosynthetic) THERAPEUTIC INDICATION MACROPIN (insulin, human biosynthetic) is indicated for the treatment of insulin requiring diabetic patients. MACROPIN R only should be used for the treatment of emergencies such as diabetic coma and pre-coma and in diabetics undergoing surgery, but not MACROPIN N, or MACROPIN 70/30. In switching patients from animal source [...]
Read MoreSTIMUS
STIMUS 2 M.I.U. ( Interferon gamma-1 b) Therapeutic indications – STIMUS is indicated for reducing the frequency and severity of serious infections associated with Chronic Granulomatous Disease. – STIMUS is indicated for delaying time to disease progression in patients with severe, malignant osteopetrosis. – Rheumatoid arthritis. – Hepatic fibrosis. Download details
Read MorePEGCYTE
PEGCYTE (Pegfilgrastim 6mg) Therapeutic indications Pegcyte Reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes). Download details
Read MoreFIBRICIN
FIBRICIN (Reteplase 18,1 mg ) Therapeutic indications Fibricin is indicated for use in the management of acute myocardial infarction (AMI) in adults for the improvement of ventricular function following AMI, the reduction of the incidence of congestive heart failure and the reduction of mortality associated with AMI. Treatment should be initiated as soon as possible [...]
Read MoreFICOCYTE
FICOCYTE 48 MU Therapeutic indications Fycocyte is indicated for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes) and for the reduction in the duration of neutropenia in patients undergoing myeloablative therapy [...]
Read MoreFERONSURE
FERONSURE (Recombinant human Interferon alfa – 2a, 3 M.I.U) Therapeutic indications Feronsure is indicated for the treatment of: – The efficacy of interferon alfa-2a in the treatment of hepatitis C is enhanced when combined with ribavirin. Feronsureshould be given alone mainly in case of intolerance or contraindication to ribavirin. – Hairy cell leukaemia. – AIDS [...]
Read MoreNANOKINE
NANOKINE (Erythropoietin alfa) Therapeutic indications Treatment of symptomatic anaemia associated with chronic renal failure (CRF) in adult and paediatric patients: – Treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis. – Treatment of severe anaemia of renal origin accompanied by clinical symptoms in [...]
Read MorePEGNANO
PEGNANO (Peginterferon alfa – 2a) Therapeutic indications Chronic hepatitis B: Pegnano is indicated for the treatment of HBeAg-positive or HBeAg-negative-chronic hepatitis B in adult patients with compensated liver disease and evidence of viral replication, increased ALT and histologically verified liver inflammation and/or Chronic hepatitis C: Pegnano is indicated for the treatment of chronic hepatitis C [...]
Read More